NCT02991209View on ClinicalTrials.gov

Study of Testosterone vs Placebo in Testicular Cancer Survivors

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions
Metabolic SyndromeTesticular CancerLeydig Cell Failure in Adult
Interventions
DRUG

Testosterone

DRUG

Placebos

Trial Locations (1)

2100

Rigshospitalet, Copenhagen

All Listed Sponsors
lead

Mikkel Bandak

OTHER

NCT02991209 - Study of Testosterone vs Placebo in Testicular Cancer Survivors | Biotech Hunter | Biotech Hunter